Report Categories
View AllRecent Articles
View All
Is Cenovus Cve Stock A Top Performer Price At 25.92 Up 1.01 20260410
RCKT Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Clinical Progress
Power Integrations POWI Q1 2026 Earnings EPS Surpasses Estimates as Revenue Details Remain Undisclosed
VAL Q1 2026 Earnings EPS Misses Estimates as Operational Headwinds Persist
HGTY Q1 2026 Earnings NarrowerThanExpected Loss Drives Small Beat Shares Slip
CANF Q4 2023 Earnings EPS Surprise of 96 as Biotech Reports NarrowerThanExpected Loss